Drug intelligence / Profile preview

oats snack bar

Development stage: Unknown
Lead developer: Universidad Autónoma de Querétaro
Administration: Oral

Overview

The oats snack bar is a functional food product developed as an alternative for the management of hypertriglyceridemia, a significant risk factor for cardiovascular disease. This product incorporates common beans (Phaseolus vulgaris L.) and oats, which are recognized sources of bioactive compounds. These compounds include phenolic compounds, total dietary fiber (insoluble and soluble fiber, resistant starch, and oligosaccharides), saponins, and phytosterols, all of which are believed to exert hypolipidemic effects. The product has been investigated in clinical trials to assess its impact on serum triglycerides and plasma proteins involved in lipid metabolism.

Other names: baked beans-oats snack bar

Targets

AMY (Pancreatic alpha-amylase)PNLIP (Pancreatic triacylglycerol lipase)Sucrase-Isomaltase

Beyond the preview

Go deeper on oats snack bar.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on oats snack bar.

Explore the full profile